PL1660134T3 - Koniugaty hydroksyalkiloskrobi i G-CSF - Google Patents
Koniugaty hydroksyalkiloskrobi i G-CSFInfo
- Publication number
- PL1660134T3 PL1660134T3 PL04763853T PL04763853T PL1660134T3 PL 1660134 T3 PL1660134 T3 PL 1660134T3 PL 04763853 T PL04763853 T PL 04763853T PL 04763853 T PL04763853 T PL 04763853T PL 1660134 T3 PL1660134 T3 PL 1660134T3
- Authority
- PL
- Poland
- Prior art keywords
- csf
- conjugates
- hydroxyalkyl starch
- hydroxyalkyl
- starch
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2003/008859 WO2004024777A1 (en) | 2002-09-11 | 2003-08-08 | Hydroxyalkyl starch derivatives |
| PCT/EP2003/008858 WO2004024761A1 (en) | 2002-09-11 | 2003-08-08 | Hasylated polypeptides, especially hasylated erythropoietin |
| PCT/EP2003/008829 WO2004024776A1 (en) | 2002-09-11 | 2003-08-08 | Method of producing hydroxyalkyl starch derivatives |
| US55228104P | 2004-03-11 | 2004-03-11 | |
| EP04005874 | 2004-03-11 | ||
| EP04763853A EP1660134B1 (en) | 2003-08-08 | 2004-08-06 | Conjugates of hydroxyalkyl starch and g-csf |
| PCT/EP2004/008818 WO2005014050A2 (en) | 2003-08-08 | 2004-08-06 | Conjugates of hydroxyalkyl starch and g-csf |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1660134T3 true PL1660134T3 (pl) | 2011-05-31 |
Family
ID=34139848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04763853T PL1660134T3 (pl) | 2003-08-08 | 2004-08-06 | Koniugaty hydroksyalkiloskrobi i G-CSF |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1660134B1 (pl) |
| KR (1) | KR101154343B1 (pl) |
| AU (1) | AU2004262921B2 (pl) |
| CA (1) | CA2534418A1 (pl) |
| MX (1) | MXPA06001358A (pl) |
| PL (1) | PL1660134T3 (pl) |
| RU (1) | RU2370281C2 (pl) |
| WO (1) | WO2005014050A2 (pl) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10209822A1 (de) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid |
| DE10209821A1 (de) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung von Proteinen an ein modifiziertes Polysaccharid |
| RU2329274C2 (ru) | 2002-09-11 | 2008-07-20 | Фрезениус Каби Дойчланд Гмбх | Способ получения производных гидроксиалкилкрахмала |
| ES2314238T3 (es) | 2002-10-08 | 2009-03-16 | Fresenius Kabi Deutschland Gmbh | Conjugados de oligosacaridos farmaceuticamente activos. |
| WO2005014655A2 (en) | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
| CA2558738C (en) | 2004-03-11 | 2013-02-05 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
| CN102302787A (zh) * | 2004-03-11 | 2012-01-04 | 费森尤斯卡比德国有限公司 | 羟烷基淀粉和蛋白质的接合物 |
| JP2009544680A (ja) | 2006-07-25 | 2009-12-17 | リポクセン テクノロジーズ リミテッド | ポリサッカライドによるタンパク質のｎ末端誘導体化 |
| MX2010002448A (es) | 2007-08-27 | 2010-10-04 | Biogenerix Ag | Formulacion liquida del g-csf conjugado. |
| EP2070950A1 (en) | 2007-12-14 | 2009-06-17 | Fresenius Kabi Deutschland GmbH | Hydroxyalkyl starch derivatives and process for their preparation |
| WO2011131720A1 (en) | 2010-04-20 | 2011-10-27 | Octapharma Ag | New stabilizing agent for pharmaceutical proteins |
| JP2014521594A (ja) | 2011-05-25 | 2014-08-28 | アミリン・ファーマシューティカルズ，リミテッド・ライアビリティ・カンパニー | 長持続期間デュアルホルモンコンジュゲート |
| CA2907371A1 (en) * | 2013-03-20 | 2014-09-25 | Fresenius Kabi Deutschland Gmbh | Hydroxyalkyl starch derivatives as reactants for coupling to thiol groups |
| WO2014147173A1 (en) * | 2013-03-20 | 2014-09-25 | Fresenius Kabi Deutschland Gmbh | Hydroxyalkyl starch derivatives as reactants for coupling to thiol groups |
| RU2546297C1 (ru) * | 2013-11-19 | 2015-04-10 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт фармакологии" Сибирского отделения Российской академии медицинских наук | Средство, улучшающее реологические свойства крови |
| WO2015130963A2 (en) | 2014-02-27 | 2015-09-03 | Xenetic Biosciences, Inc. | Compositions and methods for administering insulin or insulin-like protein to the brain |
| EP3114138B1 (en) | 2014-03-05 | 2021-11-17 | Pfizer Inc. | Improved muteins of clotting factor viii |
| RU2625039C1 (ru) * | 2016-07-12 | 2017-07-11 | Федеральное Государственное Бюджетное Учреждение Науки Институт Химии Коми Научного Центра Уральского Отделения Российской Академии Наук | Инъекционная лекарственная форма гидрофильного конъюгата гидроксиэтилкрахмала и 2,6-диизоборнил-4-метилфенола, способ ее получения и применения для лечения сердечно-сосудистых заболеваний |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5621039A (en) * | 1993-06-08 | 1997-04-15 | Hallahan; Terrence W. | Factor IX- polymeric conjugates |
| DE19628705A1 (de) | 1996-07-08 | 1998-01-15 | Fresenius Ag | Neue Sauerstoff-Transport-Mittel, diese enthaltende Hämoglobin-Hydroxyethylstärke-Konjugate, Verfahren zu deren Herstellung, sowie deren Verwendung als Blutersatzstoffe |
| CA2233725A1 (en) * | 1998-03-31 | 1999-09-30 | Hemosol Inc. | Hemoglobin-hydroxyethyl starch complexes |
| DE10112825A1 (de) * | 2001-03-16 | 2002-10-02 | Fresenius Kabi De Gmbh | HESylierung von Wirkstoffen in wässriger Lösung |
| DE10209821A1 (de) * | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung von Proteinen an ein modifiziertes Polysaccharid |
| RU2329274C2 (ru) * | 2002-09-11 | 2008-07-20 | Фрезениус Каби Дойчланд Гмбх | Способ получения производных гидроксиалкилкрахмала |
-
2004
- 2004-08-06 EP EP04763853A patent/EP1660134B1/en not_active Expired - Lifetime
- 2004-08-06 WO PCT/EP2004/008818 patent/WO2005014050A2/en not_active Ceased
- 2004-08-06 AU AU2004262921A patent/AU2004262921B2/en not_active Ceased
- 2004-08-06 MX MXPA06001358A patent/MXPA06001358A/es active IP Right Grant
- 2004-08-06 RU RU2006106926/15A patent/RU2370281C2/ru not_active IP Right Cessation
- 2004-08-06 PL PL04763853T patent/PL1660134T3/pl unknown
- 2004-08-06 KR KR1020067002747A patent/KR101154343B1/ko not_active Expired - Fee Related
- 2004-08-06 CA CA002534418A patent/CA2534418A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005014050A2 (en) | 2005-02-17 |
| RU2006106926A (ru) | 2007-09-20 |
| AU2004262921B2 (en) | 2010-05-13 |
| CA2534418A1 (en) | 2005-02-17 |
| EP1660134B1 (en) | 2010-12-29 |
| KR20060037431A (ko) | 2006-05-03 |
| MXPA06001358A (es) | 2006-05-15 |
| EP1660134A2 (en) | 2006-05-31 |
| AU2004262921A1 (en) | 2005-02-17 |
| KR101154343B1 (ko) | 2012-07-05 |
| WO2005014050A3 (en) | 2005-04-14 |
| RU2370281C2 (ru) | 2009-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200600651B (en) | Conjugates of hydroxyalkyl starch and G-CSF | |
| PL1660134T3 (pl) | Koniugaty hydroksyalkiloskrobi i G-CSF | |
| AU2003284001A8 (en) | Triazolone and triazolethione derivatives | |
| EP1613274A4 (en) | CONJUGATES COMPRISING THE HUMAN INTERLEUKINE 18 THERE AND 18 MUTANTS OF THESE CONJUGATES BY SUBSTITUTION | |
| PL377791A1 (pl) | Pochodne 3-aminopiperydyny i sposoby ich wytwarzania | |
| IL163691A0 (en) | 5-Pphenylthiazole derivatives and use as pi3 kinase | |
| AU2003214945A8 (en) | Multi-function catheter and use thereof | |
| IL163277A (en) | Controlled synthesis of ziprasidone and compositions thereof | |
| IL165249A0 (en) | Hapten-carrier conjugates and uses thereof | |
| ZA200501725B (en) | Hydroxyalkyl starch derivatives | |
| AU2003233069A8 (en) | Gel and powder making | |
| EP1539692A4 (en) | FURANO DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF | |
| IL163868A0 (en) | Hermiasterlin derivatives and uses thereof | |
| AU2003299441A8 (en) | Nf-hev compositions and methods of use | |
| IL170313A (en) | Diarylcycloalkyl derivatives and pharmaceutical compositions comprising them | |
| TWI349670B (en) | Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones | |
| AU2003296369A8 (en) | Imminoamines and preparation thereof | |
| IL173187A0 (en) | Conjugates of hydroxyalkyl starch and g-csf | |
| AU2003213120A8 (en) | Human rnase iii and compositions and uses thereof | |
| EP1539191A4 (en) | COMPOSITIONS CONTAINING GLYCO ALKALOIDS AND THEIR VARIOUS USES | |
| GB2384705B (en) | Cosmetic and related compositions | |
| AU2003296871A8 (en) | Point feeder and use of point feeder | |
| SI1392670T1 (sl) | Substituirani C-furan-2-il-metilaminski in C-tiofen-2-il-metilaminski derivati | |
| SI1660134T1 (sl) | Konjugati hidroksialkil ĺ kroba in g-csf | |
| PL369327A1 (pl) | Synteza 2-aralkoksyadenozyn i 2-alkoksyadenozyn |